ExploreWatchlistsPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Revenue

SATO PHARMACEUTICAL CO.,LTD. (E00954)

Market cap
P/E ratio
Sato Pharmaceutical develops and sells over-the-counter medicines, prescription drugs, and health products to consumers and medical institutions globally.
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndRevenue (Million JPY)YoY (%)
Jul 31, 202347,915+7.69%
Jul 31, 202244,492+3.11%
Jul 31, 202143,151-5.93%
Jul 31, 202045,873+0.35%
Jul 31, 201945,715+9.66%
Jul 31, 201841,688+5.63%
Jul 31, 201739,467+1.46%
Jul 31, 201638,898+0.44%
Jul 31, 201538,729-0.19%
Jul 31, 201438,804+1.81%
Jul 31, 201338,113+4.36%
Jul 31, 201236,522+3.38%
Jul 31, 201135,328

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat